U.S. Physical Therapy share price today

U.S. Physical Therapy, Inc.'s share price was $89.18 at the close on 4 November 2026. That is 16.2% above its average price over the last 200 trading days. In the last 52 weeks it traded between $59 and $89, and at that close it was at the high of that range.

A share price tends to move through four phases: moving sideways (stage 1), rising (stage 2), stalling near a high (stage 3) and falling (stage 4). The phase helps read everything below.

Over the past 13 weeks it has done better than the S&P 500, and it has stayed ahead for 15 weeks in a row.

Over the last 1 year the share price moved +20% while the S&P 500 moved +23%, so it is behind the index over that whole period. The chart above shows the 13-week comparison for every week.

This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row.

U.S. Physical Therapy, Inc. paid $1.82 per share over the last four reported quarters. The most recent declaration was $0.46 for Jun 2026. At today's price of $89.18 that is a yield of 2.04%, based on dividends already paid, not a forecast.

A dividend is cash paid out for each share. The 12-month total is the four most recent quarters added together.

U.S. Physical Therapy is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list.

U.S. Physical Therapy, Inc. earned $3.8 M of net profit in the Jun 2026 quarter, −56.8% on the same quarter a year earlier. Full-year FY25 profit was $21.6 M. Over 4 years profit has grown −8.8% a year on average. That is 1.8% of the quarter's revenue. The same quarter a year earlier earned $8.8 M.

Net profit is what is left after every cost, interest and tax. Earnings per share, dividends and book value all grow from it.

3 of the last 12 reported quarters were loss-making.

For the full year, FY25 profit was $21.6 M (−22.2% on the year before).

Why profit moved: revenue changed +8.5% on a year earlier and the margin moved −1.5 percentage points. Sales did the work, and the margin was about flat.

On average over the last four quarters, profit changed −82.6% and revenue +11.6%. Profit is growing slower than sales: rising costs are taking part of the growth.

U.S. Physical Therapy, Inc. reported $212 M of revenue in the Jun 2026 quarter, +8.5% on the same quarter a year earlier. That is the 12th quarter in a row with growth on the year before. Over 4 years it has grown 12.1% a year on average. The last full year, FY25, came in at $773 M.

Revenue is everything the company billed its customers in the period.

The last four reported quarters add to $804 M.

FY25 revenue was $773 M, +16.4% on the year before.

Recent pace: the last four quarters grew +11.6% on average, against 12.1% a year over the longer run, so this year is growing at about the same pace as its own long-run rate.

Is growth speeding up? Revenue over the last 12 months grew +11.4%, against +13.8% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −92.3%, against −59.1% a year (rolling over).

U.S. Physical Therapy, Inc.'s operating margin was 11.1% in the Jun 2026 quarter, 1.5 percentage points lower than the same quarter a year ago. Across 5 years it has been between 10.4% and 14.4%. The latest quarter is within that range.

Operating margin is what is left from every $100 of sales after the costs of running the business, before interest and tax. It shows pricing power and cost control.

Why the margin moved: operating margin changed −1.5 percentage points on the year while gross margin changed −1.9 points. So the drop came mostly from the gross margin, which means input costs and prices charged.

Over the last 3 years, 344% of U.S. Physical Therapy, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $75.1 M of operating cash against $21.6 M of profit. After $14.1 M of spending on assets, $61.0 M was left over as free cash.

The profit and loss account shows what was earned. The cash-flow statement shows the cash that actually came in. Comparing operating cash flow with profit is one of the best checks that a profit is real.

Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year.

Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason.

What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building.

U.S. Physical Therapy, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $32.6 M on assets over the last 3 years. Averaged over those years that is 1.4% of FY25 revenue a year.

Working capital is the cash tied up between paying suppliers and getting paid. Debtor days: how long customers take to pay. Inventory days: how long stock sits. The cash cycle: the whole loop, in days of sales.

Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn.

Spending on assets: $32.6 M over the last 3 years.

In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns.

U.S. Physical Therapy, Inc.'s P/E is 508.0×, about the highest it has ever been. Its usual P/E (the middle reading) is 60.2×, over 1 year of weekly prices. This compares the share price with the company’s own past. It does not say what the business is worth.

P/E is the share price divided by a year's profit per share: how many dollars the market pays for each dollar of yearly profit.

Why the multiple is where it is: over the past year earnings per share moved −22.8% while the price moved +20.7%. The price did better than earnings, which pushed the multiple up within its own range.

In short: the multiple is high against its own past, so the earnings trend underneath matters more than the multiple.

U.S. Physical Therapy, Inc.'s business is getting worse. Profit and EPS growth are shrinking: profit growth is −92.3% in the latest quarter, against +155.4% at its best in 12 quarters, with ROCE steady at 7.2%. This is based on 12 quarters of 4 measures.

Every business is somewhere on a path of getting better or worse, and this section names where. The last 12 quarters of growth in revenue, profit and earnings per share, plus the return the business earns on its capital, are read as lines. Getting worse: the lines are falling. Turning around: a low point has just formed and the last few quarters are rising from it. Getting better: the rise from the low has lasted. Growing steadily: steady growth with healthy returns. Slowing from a peak: still high, but slowing. When the lines disagree the result is mixed; too little history means no reading. CAGR (compound annual growth rate) is the steady yearly rate that would turn the starting value into the latest one. It is the fairest way to compare growth over different periods. If the 1-year figure is much bigger than the 10-year one, recent growth is running faster than the long-run trend. A dash means there is no figure for that period, or the starting year was a loss, where a growth rate means nothing.

Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind.

Compound annual growth rate (%)

Compound annual growth rate over each period, %. Revenue, profit and EPS come from yearly figures; the stock price row is price growth over the same periods. A dash means no figure for that period, or the starting year was a loss.

U.S. Physical Therapy, Inc. earned a ROE of 3% in FY25. Its return on capital used (ROIC) is 3.3 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 2.8% net margin and 0.64× asset turnover (sales divided by assets).

Return on equity (ROE) is the profit the business earns on its shareholders’ money. We do not have the full capital split, so ROE is the longest history we can draw here.

Why the return is what it is (FY25): a 2.8% net margin × 0.64× asset turnover × 1.56× leverage (assets divided by equity) ≈ 2.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed.

The key test, return on capital used minus the cost of capital: 5.3% − 8.6% = −3.3 percentage points. The 8.6% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve.

U.S. Physical Therapy, Inc. has total debt of $386 M against shareholder equity of $767 M as of Jun 2026, so its debt is 0.50× its equity. Year by year, that ratio went from 0.49 in FY21 to 0.41 in FY25. Keep that borrowing in mind when reading the returns on this page.

Debt-to-equity shows how much of the business is paid for with borrowed money. Lower is safer, and the direction matters as much as the level.

8.2% of U.S. Physical Therapy, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 6.3 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead.

There is no quarter-by-quarter list of owners here, so we look at short interest: the share of tradable shares held in short positions, which gain if the price falls.

It is a single reading at one point in time; we do not have its history.

Why it is at this level: the figure does not say who has the short positions or why, so we show the level without guessing the story.

For U.S. Physical Therapy, Inc., the Z-score is 2.59. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is in the grey area between the two. It estimates how far the balance sheet is from trouble; it is not a forecast of failure.

The Z-score estimates how far a company is from balance-sheet trouble. Above about 3 is safe; below about 1.8 is the danger zone. It was built for manufacturers, so it is not used for banks and lenders.

Why it matters: a Z-score of 2.59 is in the grey area, neither clearly safe nor clearly in trouble.

There is no score against its industry: U.S. Physical Therapy, Inc. is not among the largest members shown in this industry comparison for Medical Care Facilities.

The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown.

No sector comparison is shown here, not among the largest members shown in this industry comparison.

U.S. Physical Therapy is the 31st largest of 38 Medical Care Facilities companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: The Pennant Group, Inc., Nutex Health Inc. and InnovAge Holding Corp. Just below it: GMR Solutions Inc., The Oncology Institute, Inc. and Charming Medical.

Medical Care Facilities companies close in size

28. The Pennant Group, Inc. $1.5 billion
29. Nutex Health Inc. $1.4 billion
30. InnovAge Holding Corp. $1.3 billion
31. U.S. Physical Therapy, Inc. $1.3 billion
32. GMR Solutions Inc. $963 million
33. The Oncology Institute, Inc. $707 million
34. Charming Medical Limited $504 million

All 38 Medical Care Facilities companies, largest first

Companies close in size in other industries

2253. InnovAge Holding Corp. $1.3 billion · Medical Care Facilities
2254. Adecoagro S.A. $1.3 billion · Farm Products
2255. U.S. Physical Therapy, Inc. $1.3 billion
2256. Ascentage Pharma Group International $1.3 billion · Biotechnology
2257. Lucid Group, Inc. $1.3 billion · Auto Manufacturers

Sector Alpha, written by code from the published numbers. Data as of 4 November 2026.

Every chart on this page is drawn by code from the published figures, with no forecasts and no price opinions.

See the plain-text version of this page.